OMLONTI

This brand name is authorized in United States

Active ingredients

The drug OMLONTI contains one active pharmaceutical ingredient (API):

1 Omidenepag UNII G0G0H52U6K - OMIDENEPAG ISOPROPYL

Omidenepag is a relatively selective EP2 receptor agonist which decreases intraocular pressure (IOP). The exact mechanism of action is unknown. Elevated IOP represents a major risk factor for glaucomatous field loss. Read about Omidenepag

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OMLONTI Ophthalmic solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EX06		S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EX Other antiglaucoma preparations
Discover more medicines within S01EX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 65086-002